$30.35
-1.7%The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors, who are independent or who require some support. As of December 31, 2021, the company operated 88 home health and hospice agencies, and 54 senior living communities with 4127 Senior Living units in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.
Last Annual Value
0.00
3-Year CAGR
%
5-Year CAGR
%
10-Year CAGR
%
| Company | Investments in Property, Plant, and Equipment | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() The Pennant Group, Inc. NASDAQ:PNTG | 0.00 | N/A | N/A | N/A | |
![]() HealthStream, Inc. NASDAQ:HSTM | -3.69M | N/A | N/A | N/A | |
![]() Integra LifeSciences Holdings Corporation NASDAQ:IART | 0.00 | N/A | N/A | N/A | |
![]() ProKidney Corp. NASDAQ:PROK | -15.20M | N/A | N/A | N/A | |
![]() Sonida Senior Living, Inc. NYSE:SNDA | -33.28M | N/A | N/A | N/A | |
![]() Bicara Therapeutics Inc. Common Stock NASDAQ:BCAX | -280.00K | N/A | N/A | N/A | |
![]() Kura Oncology, Inc. NASDAQ:KURA | -6.64M | N/A | N/A | N/A | |
![]() CorMedix Inc. NASDAQ:CRMD | -2.26M | N/A | N/A | N/A | |
![]() InnovAge Holding Corp. NASDAQ:INNV | -6.26M | N/A | N/A | N/A | |
![]() AMN Healthcare Services, Inc. NYSE:AMN | 0.00 | N/A | N/A | N/A | |
![]() EyePoint Pharmaceuticals, Inc. NASDAQ:EYPT | -3.28M | N/A | N/A | N/A |
Continue your PNTG research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.